New Exclusive Licensing Agreement with Cannabiniers, Conducted via Lighthouse Strategies with Skinvisible (SKVI) Subsidiary

New Exclusive Licensing Agreement with Cannabiniers, Conducted via Lighthouse Strategies with Skinvisible (SKVI) Subsidiary
New Exclusive Licensing Agreement with Cannabiniers, Conducted via Lighthouse Strategies with Skinvisible (SKVI) Subsidiary

  • Cannabis industry pioneer Cannabiniers will distribute treatments utilizing Invisicare®, a patented polymer delivery system
  • Agreement marks continued growth for Skinvisible’s subsidiary Ovation Science Inc.
  • Patented delivery technology enables improved controlled release of topically applied products

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has announced that its subsidiary Ovation Science Inc. has forged a definitive license agreement with Lighthouse Strategies LLC, through its multifaceted cannabis technology and brand management company Cannabiniers, to utilize the Company’s products formulated with its patented pharmaceutical polymer in serving the U.S. cannabis market (http://cnw.fm/Pz4rQ).

The Lighthouse agreement grants the company exclusive use of Ovation’s new patented topical and transdermal formulations for improved delivery of ingredients in select markets within the United States. This latest agreement is yet another mark of Ovation’s expansion, which has included another recently signed licensing agreement granting Canopy Growth Corp. exclusive rights to Ovation’s cannabis formulations in Canada (http://cnw.fm/N8XsZ).

Read the full article

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer